 |
인쇄하기
취소
|
Kyungdong's Reductil modified new drug to be soon approved.
Kyungdong pharmaceutical company announced on July 13 that a modified drug of sibutramine (Reductil), an anti-obesity drug, called Silumin capsule would be approved by the KFDA shortly around the coming Oct.
Kyungdong said that they successfully completed the clinical studies over the new derivative of sibutramine, Silumin 11.3 mg cap and 16.95mg cap.
Its pre-clinical study was performe...
Kyungdong said that they successfully completed the clinical studies over the new derivative of sibutramine, Silumin 11.3 mg cap and 16.95mg cap.
Its pre-clinical study was performe...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.